This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barrett AJ, Le Blanc K . Immunotherapy prospects for acute myeloid leukaemia. Clin Exp Immunol 2010; 161: 223–232.
Vago L, Perna SK, Zanussi M, Mazzi B, Barlassina C, Stanghellini MTL et al. Loss of mismatched HLA in leukemia after stem cell transplantation. N Engl J Med 2009; 361: 478–488.
Baessler T, Krusch M, Schmiedel BJ, Kloss M, Baltz KM, Wacker A et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. Cancer Res 2009; 69: 1037–1045.
Baessler T, Charton JE, Schmiedel BJ, Grünebach F, Krusch M, Wacker A et al. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK cell reactivity against human acute myeloid leukemia in humans. Blood 2010; 115: 3058–3069.
Schäkel K, Kannagi R, Kniep B, Goto Y, Mitsuoka C, Zwirner J et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 2002; 17: 289–301.
Schäkel K, von Kietzell M, Hänsel A, Ebling A, Schulze L, Haase M et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are strictly controlled by contact with erythrocytes. Immunity 2006; 24: 767–777.
Schmitz M, Zhao S, Deuse Y, Schäkel K, Wehner R, Wöhner H et al. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J Immunol 2005; 174: 4127–4134.
Wehner R, Löbel B, Bornhäuser M, Schäkel K, Cartellieri M, Bachmann M et al. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells. Int J Cancer 2009; 124: 358–366.
Acknowledgements
The technical assistance of Bärbel Löbel, Karin Günther, Jule Kriegel and Anne Seltmann (all from the Institute of Immunology) is greatly appreciated. We also thank Silke Soucek and Michael Kramer for providing the characteristics of the AML cells. This work was supported by grants from the Deutsche Forschungsgemeinschaft to MB and GE (SFB655, project B2 and B7) and from the Medical Faculty, Technical University of Dresden to RW.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wehner, R., Schumacher, P., Bornhäuser, M. et al. Acute myeloid leukemia cells fail to activate native human dendritic cells: a potential mechanism of immune evasion. Leukemia 24, 1965–1967 (2010). https://doi.org/10.1038/leu.2010.189
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.189
This article is cited by
-
Interferon-α in acute myeloid leukemia: an old drug revisited
Leukemia (2011)